S32
Conditions
Interventions
Group 1: Patients who have received a medical recommendation for a SACRONAIL implant are examined at different times before and after surgery. The maintenance / improvement of the quality of life, pat
Sponsors
SIGNUS Medizintechnik GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Medical recommendation for the insertion of the SACRONAIL implant - Age> 18 years
Exclusion criteria
Exclusion criteria: - Age <18 years - Patients incapable of giving consent, e.g. due to cognitive limitations - Pregnant and breastfeeding women - Patients for whom there is no consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study is to evaluate the clinical outcome one year after surgery. The clinical result is assessed with the evaluation system by Rommens et al (Rommens, et al., 2002). This scoring has already been used for traumatic (Rommens, et al., 2002) and geriatric patients (Mehling, et al., 2012) and is therefore considered appropriate. Rommens, P. M. and Hessmann, M. H. 2002. Staged Reconstruction of Pelvic Ring Disruption: Differences in Morbidity, Mortality, Radiologic Results, and Functional Outcomes Between B1, B2 / B3, and C-Type Lesions. Journal of Orthopedic Trauma. 2002, pp. 92-98. Mehling, I., Hessmann, M. H. and Rommens, P. M. 2012. Stabilization of fatigue fractures of the dorsal pelvis with a trans-sacral bar. Operative technique and outcome. Injury. 2012, pp. 446-451. | — |
Secondary
| Measure | Time frame |
|---|---|
| Three different secondary endpoints for assessing efficiency were defined: 1. Maintaining / improving the patient's quality of life and patient satisfaction. (SF-12, WET PI) 2. The functionality of the pelvic ring. (Majeed Score, Pelvic Outcome Scale) 3. The stabilization of the pelvic ring. Assessment of the safety of the implant and surgery is done by assessing the secondary endpoints. (Considering bone healing or the non-occurrence of a fracture) | — |
Countries
Germany
Contacts
Public ContactIsabell Hock
SIGNUS Medizintechnik GmbH
Outcome results
None listed